- Home
- / Editas Medicine
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Editas Medicine financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$3.1
2024-10-29
Market Capitalization
$256.5 M
2024-10-29
Revenue
$40.5 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 23, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.1M | 13.7M | 31.9M | 20.5M | 90.7M | 25.5M | 19.7M | 78.1M | 32.3M | 40.5M |
| General and administrative expense | 46.3M | 50.5M | 55.0M | 64.6M | 67.6M | 76.2M | 70.7M | 69.7M | 72.0M | 49.9M |
| Operating expense total | 103.2M | 133.7M | 145.7M | 161.5M | 225.6M | 245.7M | 247.3M | 271.2M | 139.9M | |
| EBIT | (97.2M) | (119.9M) | (113.7M) | (140.9M) | (134.8M) | (193.1M) | (225.9M) | (169.2M) | (251.2M) | (160.0M) |
| EBIT margin, % | -1605.6% | -873.6% | -356.1% | -686.4% | -148.6% | -1146.3% | -216.6% | -777.2% | -394.9% | |
| Investment income | 62.0K | (978.0K) | 3.4M | 7.3M | 2.6M | 2.3M | 4.2M | 17.6M | 14.1M | 8.3M |
| Interest expense | 5.0K | 391.0K | 3.8M | 7.2M | 2.1M | |||||
| Net Income | (97.2M) | (120.3M) | (110.0M) | (133.7M) | (116.0M) | (192.5M) | (220.4M) | (153.2M) | (237.1M) | (160.1M) |
| EPS | (3.2) | (2.0) | (2.9) | (1.8) |